Optimize Regeneration Using
the Purest and Most Potent
Tissue Allograft
For homologous use only.
Introducing
GO FAR BEYOND SINGLE MATERIAL ALLOGRAFT
TO FOUR MATERIALS COMBINED:
Placenta, amnion membrane, Wharton’s jelly, and amniotic fluid.
GO FAR BEYOND OUTDATED INVASIVE
ADIPOSE AND BONE MARROW ASPIRATE TO
OFF THE SHELF INJECTABLE SIGNALING CELLS
Potent PMSCs, growth factors, exosomes, secretomes, miRNA+
RICHGEN Comparison Chart
Available in .5 ml, 1 ml, and 2 ml vials
- Combined FOUR materials enhance regeneration
- MSCs CD 73, 90, 105 plus CD 45
- Full flexible signaling messaging
- All 1,500 growth factor proteins
- Exosomes, cytokines, secretomes, miRNA
- Reduce time, eliminating surgery
- Cells are never centrifuged
- ISO 7 certified clean room and ISO 5 production
hoods at tissue processing lab
- High viability increases after thawing
- Collagen substrates II, IV, V and VII
- Pluripotent PMSCs
- Fibroblasts, Keratinocytes
- Epithelial & Endothelial cells
- Reduce liability, eliminating surgery
- Provide patient-improved regeneration
- Only freeze outer membrane of cells
- For homologous use only
- Does not contain umbilical cord blood
Additional RICHGEN Products:
THERAPY
LASER THERAPY
RICHGEN Membrane is for sale in Canada.
Currently RICHGEN Tissue Allograft
is not yet for sale in Canada.
Physicians
RICHGEN MSC unparalleled products are
undifferentiated pluripotent cellular
components with all supporting growth
factors, bioactive cytokines and other
enhancing components.
The RICHGEN potent signaling cells are immunomodulating and they have the ability to secrete via exosomes and vesicles the appropriate combination of growth factors and miRNA to influence the surrounding tissue to regenerate.
The extracellular and intracellular messaging from the RICHGEN growth factors BMP 4, 5 and 7 enhance bone growth, the alpha2 macroglobulin enhances anti-inflammatory activity in the joints, the collagen substrates I, III, IV, V and VI, fibronectin and laminin enhance wound healing. The MSCs have an immuno-modulating effect on the macrophages and CD45 expresses T cell activation. The placental allograft components drive the development of fully functional cellular repair and regeneration. Bone marrow aspirate cells tend to lend themselves to marginally functional cellular development and the cells express inflexible signaling instructions. The RICHGEN cellular components have an immuno-modulatory effect and a trophic effect. In addition, RICHGEN products are never centrifuged and not combined with millions of lecithin that can artificially increase cell counts. RICHGEN is a pure product carefully prepared for maximum effect and safety.
UCB cord cells are only multi-potent and do not differentiate. To create optimization, injecting with RICHGEN four material flowable allograft with the natural birth components will maximize regeneration. What's more, RICHGEN cells important proprietary processing does not crystallize the inner cells in the freezing process. The result is our thawed product, which is the most leading-edge available today and has the highest viability for multiple materials. Viability increases post thaw per independent lab testing. Doctors are calling these the “Holy Grail” of regenerative therapy, based upon their ease of use and significant results, compared to what was used prior to the emergence of RICHGEN. Visit the Physician Portal to see the RICHGEN white paper.
Welcome to RichSource
RICHGEN Tissue Allograft
The most bioactive human tissue allograft regenerative combination products on the market - are here.
Years of research and testing combining placenta, Wharton’s jelly, amniotic fluid, and amnion membrane enrich and make RICHGEN products the superior choice. Yes, after years of research and development all four materials are carefully prepared to bring to market unrivaled, safe allograft products prepared in an FDA registered and inspected ISO 7 tissue processing lab in Florida, USA. See FDA Publication of 21 CFR 1271 legal interpretation of PHSA section 351 v 361 that 361 manufacturing is allowed.
The RICHGEN flowable allografts’ bioactive proteins, combined with the presence of the extracellular matrix, lamin, and fibronectin, present a functional allograft that is effective in a wide array of applications. The applications range from topical wound healing to rapid response for use in orthopedic pathologies, organ system pathologies, pain / anti-inflammatory control, scar management by following the inflammatory chemotactic pathways and providing components, immunomodulation, and scaffolding for healthy tissue generation and repair of injured tissue. For homologous use only.
RICHGEN Injectables
Physicians nationwide have advanced
their practices with RICHGEN off the shelf injectables..
Using RICHGEN products provide your patients with non-invasive, non-surgical options. Even better, they will save you time, reduce your liability and bring in a new revenue stream. Additionally, Login and see our 100% guaranteed payment plan for patient treatments using RichSource distributed RICHGEN products.
Caution: Click here for information regarding use of inferior brands
or procedures in violation of FDA and PHSA.
Aestheticians
We invite you to look into our new RICHGEN products to use post-micro-needling collagen induction replacing PRP, post-CO2 lasering, during cool sculpting, post-lipoaspiration or for wellness. RICHGEN is now replacing PRP and PRFP. The RICHGEN Matrix new facial serum is recommended to use post-treatment for 60 days in the morning after and evenings twice a day onward, to further enhance skin regeneration.
See why.
RICHGEN Facial Serum Info Card
RICHGEN Matrix Facial Serum is currently not yet for sale in Canada.
Patients
Look at our FAQ and Testimonials pages. Please contact us to be referred to one of our physicians.
